Видео ютуба по тегу Dr. Arnon Kater

Solid Results for Epcoritimab for Relapsed / Refractory CLL - Dr. Arnon Kater
Solid Results for Epcoritimab for Relapsed / Refractory CLL - Dr. Arnon Kater
Subcutaneous Epcoritamab for Richter's Syndrome - Dr. Arnon Kater ASH 2022
Subcutaneous Epcoritamab for Richter's Syndrome - Dr. Arnon Kater ASH 2022
Immune Changes After Treatment with Venetoclax + Rituximab in CLL - Dr. Arnon Kater ASH 2022
Immune Changes After Treatment with Venetoclax + Rituximab in CLL - Dr. Arnon Kater ASH 2022
Use of Bispecific Antibodies in Chronic Lymphocytic Leukemia (CLL) - Dr. Arnon Kater ASH 2021
Use of Bispecific Antibodies in Chronic Lymphocytic Leukemia (CLL) - Dr. Arnon Kater ASH 2021
CLL Horizons 2016: Watch & Wait. Dr. Arnon Kater
CLL Horizons 2016: Watch & Wait. Dr. Arnon Kater
CLL Horizons 2016: Clinical Trial Uptake and Availability. Dr Arnon Kater
CLL Horizons 2016: Clinical Trial Uptake and Availability. Dr Arnon Kater
CLL Horizons 2016: CLL and Treatment Related Complications. Dr. Ben Kennedy
CLL Horizons 2016: CLL and Treatment Related Complications. Dr. Ben Kennedy
CLL 19-10-2013 dr.A.Kater
CLL 19-10-2013 dr.A.Kater